IRadimed Corporation (IRMD)

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

The chart shows the growth of an initial investment of $10,000 in IRadimed Corporation, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.

IRadimed Corporation (IRMD) has returned -0.86% so far this year and 86.13% over the past 12 months. Looking at the last ten years, IRMD has achieved an annualized return of 18.48%, outperforming the S&P 500 Index benchmark, which averaged 12.16% per year.

Based on dividend-adjusted daily data since Jul 16, 2014, IRMD's average daily return is +0.13%, while the average monthly return is +2.66%. At this rate, your investment would double in approximately 2.2 years.

Historically, 60% of months were positive and 40% were negative. The best month was Oct 2017 with a return of +48.4%, while the worst month was Oct 2016 at -44.4%. The longest winning streak lasted 7 consecutive months, and the longest losing streak was 4 months.

On a daily basis, IRMD closed higher 50% of trading days. The best single day was Jul 30, 2019 with a return of +33.3%, while the worst single day was Oct 4, 2016 at -36.7%.

IRadimed Corporation has an annualized alpha of 26.65%, beta of 0.83, and R² of 0.08 versus S&P 500 Index. Calculated based on daily prices since July 17, 2014.

• This stock captured 186.81% of S&P 500 Index gains and 129.27% of its losses — amplifying both gains and losses, but participating more in upside than downside.
• R² of 0.08 means this stock moves largely independently of S&P 500 Index — capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

IRMD ranks 95 for risk / return — in the top 95% of stocks on our site. This means strong returns relative to risk — exactly what professional investors look for. Well-suited for investors who want to maximize return per unit of risk.

The table below present risk-adjusted performance metrics for IRadimed Corporation (IRMD) and compare them to a chosen benchmark (S&P 500 Index).

IRadimed Corporation provided a 1.26% dividend yield over the last twelve months, with an annual payout of $1.21 per share.

The table displays the monthly dividend distributions for IRadimed Corporation. The dividends shown in the table have been adjusted to account for any splits that may have occurred.

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.

The table below displays the maximum drawdowns of the IRadimed Corporation. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the IRadimed Corporation was 75.83%, occurring on Apr 5, 2017. Recovery took 369 trading sessions.

The current IRadimed Corporation drawdown is 8.42%.

The chart below shows the rolling one-month volatility.

The chart below illustrates the trends in the financial health of IRadimed Corporation over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

The Valuation section provides an overview of how IRadimed Corporation is priced in the market compared to other companies in the Medical Devices industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.